XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Income Statement [Abstract]        
Revenues $ 620,600,000 $ 559,200,000 $ 1,832,200,000 $ 1,614,900,000
Operating expenses:        
Salaries and benefits 185,500,000 162,300,000 546,300,000 468,700,000
Supplies 173,200,000 160,100,000 518,300,000 464,900,000
Professional and medical fees 68,100,000 56,800,000 198,400,000 169,700,000
Lease expense 21,600,000 23,400,000 61,800,000 68,800,000
Other operating expenses 41,000,000.0 34,100,000 116,800,000 98,500,000
Cost of revenues 489,400,000 436,700,000 1,441,600,000 1,270,600,000
General and administrative expenses 17,900,000 25,500,000 73,500,000 76,800,000
Depreciation and amortization 29,800,000 25,200,000 85,200,000 76,100,000
Transaction and integration costs 12,500,000 10,200,000 27,800,000 24,700,000
Grant funds (500,000) 0 (1,800,000) (20,000,000.0)
Loss on disposals and deconsolidations, net 2,200,000 1,900,000 3,200,000 2,000,000.0
Equity in earnings of unconsolidated affiliates (2,400,000) (2,900,000) (8,100,000) (8,500,000)
Litigation settlement 0 0 (32,800,000) 0
(Gain) loss on debt extinguishment 0 (500,000) 0 9,100,000
Other income, net (2,400,000) (500,000) (7,400,000) (3,300,000)
Total operating expenses 546,500,000 495,600,000 1,581,200,000 1,427,500,000
Operating income 74,100,000 63,600,000 251,000,000.0 187,400,000
Interest expense, net (60,700,000) (54,200,000) (173,900,000) (160,900,000)
Income before income taxes 13,400,000 9,400,000 77,100,000 26,500,000
Income tax (expense) benefit (7,800,000) (1,200,000) (13,400,000) 1,300,000
Net income 5,600,000 8,200,000 63,700,000 27,800,000
Less: Net income attributable to non-controlling interests (30,600,000) (31,100,000) (94,900,000) (98,600,000)
Net loss attributable to Surgery Partners, Inc. (25,000,000.0) (22,900,000) (31,200,000) (70,800,000)
Less: Amounts attributable to participating securities 0 0 0 (10,300,000)
Net loss attributable to common stockholders, basic (25,000,000.0) (22,900,000) (31,200,000) (81,100,000)
Net loss attributable to common stockholders, diluted $ (25,000,000.0) $ (22,900,000) $ (31,200,000) $ (81,100,000)
Net loss per share attributable to common stockholders        
Basic (in USD per share) $ (0.28) $ (0.28) $ (0.35) $ (1.19)
Diluted (in USD per share) [1] $ (0.28) $ (0.28) $ (0.35) $ (1.19)
Weighted average common shares outstanding        
Basic (shares) 88,907 80,726 88,604 68,350
Diluted (shares) [1] 88,907 80,726 88,604 68,350
[1] The impact of potentially dilutive securities for all periods presented was not considered because the effect would be anti-dilutive.